CD4+ T cells require either B cells or CD8+ T cells to control spread and pathogenesis of a neurotropic infection

Virology

Volumn 499, Issue , 2016, Pages 196-202

  Solomos, Andreas C ^a,b   O'Regan, Kevin J ^a   Rall, Glenn F ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adaptive immunity; Measles; Neuron; Transgenic mice

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE COFACTOR PROTEIN;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DISEASE TRANSMISSION; INFECTION CONTROL; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MEASLES; MEASLES VIRUS; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS REPLICATION; ANIMAL; BRAIN; C57BL MOUSE; FEMALE; HUMAN; IMMUNOLOGY; MALE; PATHOGENICITY; PHYSIOLOGY; VIRAL TROPISM; VIROLOGY; VIRULENCE;

ANIMALS; B-LYMPHOCYTES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; MALE; MEASLES; MEASLES VIRUS; MICE; MICE, INBRED C57BL; VIRAL TROPISM; VIRULENCE;

EID: 84988667019     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.09.013     Document Type: Article

References (29)

1. Aspelund, A., Antila, S., Proulx, S., Karlsen, T., Karaman, S., Detmer, M., et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212:7 (2015), 991–999.
2. Binder, G.K., Griffin, D.E., Interferon-gamma mediated site specific clearance of alphavirus from CNS neurons. Science 293 (2001), 303–306.
3. Cserr, H.F., Knopf, P.M., Cervical lymphatics, the blood brain barrier, and the immuno-reactivity of the brain: a new view. Immunol. Today 13 (1992), 507–512.
4. Dalton, D., Pitts-Meek, S., Keshav, S., Figari, I., Bradley, A., Stewart, T., Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259 (1993), 1739–1744.
5. Fang, M., Sigal, L., Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 175:10 (2005), 6829–6836.
6. Grusby, M.J., Johnson, R.S., Papaioannou, V.E., Glimcher, L.H., Depletion of CD4+ T cells in MHC class II-deficient mice. Science 253 (1991), 1417–1420.
7. Hickey, W.F., Hsu, B.L., Kimura, H., T lymphocyte entry into the CNS. J. Neurosci. Res. 28 (1991), 254–260.
8. Johnson, R.T., Viral Infections of the Nervous System. 1998, Lippincott-Raven, Philadelphia, PA.
9. Kagi, D., Liedermann, B., Burki, K., Seller, P., Odermatt, B., Olsen, K.J., et al. Cytotoxicity mediated by T cells and NK cells is greatly impaired in perforin-deficient mice. Nature 369 (1994), 31–37.
10. Kitamura, D., Roes, J., Kuhn, R., Rajewsky, K., A B cell deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350 (1991), 423–426.
11. Komatsu, T., Bi, Z., Reiss, C.S., Interferon gamma-induced type I nitric oxide sythase activity inhibits viral replication in neurons. J. Neuroimmunol. 68 (1996), 101–108.
12. Lawrence, D.M.P., Vaughn, M.M., Belman, A.R., Cole, J.S., Rall, G.F., Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and CNS disease. J. Virol. 73 (1999), 1795–1801.
13. Louveau, A., Smirnov, I., Keyes, T., Eccles, J., Rouhani, S., Peske, J., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523:7560 (2015), 337–341.
14. Muller, U., Steinhoff, U., Reis, L., Hemmi, S., Pavlovic, J., Zinkernagel, R., et al. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994), 1918–1921.
15. O'Donnell, L., Rall, G., Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin. J. Neuroimmune Pharm. 5 (2010), 443–455.
16. O'Donnell, L.A., Henkins, K.M., Kulkarni, A., Matullo, C.M., Balachandran, S., Pattisapu, A.K., et al. Interferon gamma induces protective non-canonical signaling pathways in primary neurons. J. Neurochem. 135 (2015), 309–322.
17. Parra, B., Hinton, D.R., Marten, N.W., Bergmann, C.C., Lin, M.T., Yang, C.S., et al. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162 (1999), 1641–1647.
18. Patterson, C.E., Lawrence, D.M., Echols, L.A., Rall, G.F., Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma-interferon dependent. J. Virol. 76 (2002), 4497–4506.
19. Podolsky, M., Solomos, A., Durso, L., Evans, S., Rall, G., Rose, R., Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma. J. Neuroimmunol. 25:1–2 (2012), 33–38.
20. Rall, G.F., Manchester, M., Daniels, L.R., Callahan, E.M., Belman, A.R., Oldstone, M.B.A., A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA 94 (1997), 4659–4663.
21. Ransohoff, R., Engelhardt, B., The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12 (2012), 623–635.
22. Rose, R.W., Vorobyeva, A.G., Skipworth, J.D., Nicolas, E., Rall, G.F., Altered levels of STAT-1 and STAT-3 influence the neuronal response to interferon gamma. J. Neuroimmunol. 192 (2007), 145–156.
23. Sarmiento, M., Glasebrook, A., Fitch, F., IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:6 (1980), 2665–2672.
24. Shinkai, Y., Rathbun, G., Lam, K., RAG-2 deficient mice lack mature lymphocytes owing to the inability to initiate V(D)J rearrangement. Cell 68 (1992), 855–864.
25. Solomos, A., Rall, G., Get it through your thick head: emerging principles in neuroimmunology and neurovirology redefine central nervous system “immune privilege”. ACS Chem. Neurosci. 7:4 (2016), 435–441.
26. Tishon, A., Lewicki, H., Rall, G., von Herrath, M., Oldstone, M.B.A., An essential role for type 2 interferon gamma in terminating persistent viral infection. Virology 212 (1995), 244–250.
27. Tishon, A., Lewicki, H., Andaya, A., McGavern, D., Martin, L., Oldstone, M., CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. Virology 347 (2006), 234–245.
28. Wilde, D., Marrack, P., Kappler, J., DIalynas, D., Fitch, F., Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1.5 (anti-L3T4a) blocks class I MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J. Immunol. 131:5 (1983), 2178–2183.
29. Ziljstra, M., Li, E., Sajjadi, F., Subramani, S., Jaenisch, R., Germline transmission of a disrupted beta-2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342 (1989), 435–439.